Scholars Central

Conference abstractPublished 26 Jun 2014

Current state of vascular access in chronic hemodialysis patients in Algeria

Authors: Lydia Benhocine

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

D espite all the progress made in the techniques of renal replacement therapy, hemodialysis (HD) survival depends in a large part on the quality of vascular access. In Algeria, a country with a population of 37.1 million inhabitants, more than 17,000 patients are on dialysis (98% HD) distributed in 275 hemodialysis centers across the country. We made a prospective study in order to identify what type of vascular access for hemodialysis is made on first intention and then realize a clinical expertise on the vascular access for dialysis in patients after a certain period of HD. Our study was multicenter and collated in 60 days (data collection and statistical study). 1029 chronic hemodialysis patients treated and supported in 21 hemodialysis centers (public and private center) located in the capital city of Algiers and neighboring towns. We found that sex ratio in our patients was identical and population is relatively young. Percentage of unknown nephropathy (30%) is important and alarming. The percentage of diabetic nephropathy and hypertensive join international datas. The catheter is still representing the first vascular access for HD. Despite 40% of AVF, it shows the needs of follows up and screening of patients with chronic kidney disease before the end-stage of renal disease. First seat of AVF is distal than proximal for just 50% and one patient in five has ?a poor? vasculature at less than 10 years of HD. The vasculature of hemodialysis patients is vital. It is important to preserve it carefully by encouraging education of chronic uremic patients and nursing staff and realize a careful evaluation of where the anastomosis should be performed using radiological ways if necessary. Multidisciplinary planning seems essential to achieve this goal and improve the survival of patients on chronic hemodialysis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Nephrology & Therapeutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nephrology & Therapeutics
  • SubjectNephrology & Urology
  • BylineArticles whose byline prints “Lydia Benhocine”